Risk factors for central nervous system metastasis in patients with metastatic breast cancer

By  

Medical Oncology, Vol. 24, Iss. 2, 2007-06 ,pp. : 155-161

Humana Press, Inc

Access to resources Recommend Favorite

Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: An analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998

By Bacci Gaetano   Longhi Alessandra   Ferrari Stefano   Mercuri Mario   Versari Michela   Bertoni Franco  

Acta Oncologica, Vol. 45, Iss. 4, 2006-06 ,pp. : 469-475

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy - a phase I, dose-finding study

By Lortholary A.   Maillard P.   Delva R.   Boisdron-Celle M.   Perard D.   Vernillet L.   Besenval M.   Gamelin E.  

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1773-1780

Elsevier

Access to resources Recommend Favorite

In Situ Protein Expression of RRM1, ERCC1, and BRCA1 in Metastatic Breast Cancer Patients Treated with Gemcitabine-Based Chemotherapy

By Metro G.   Zheng Z.   Fabi A.   Schell M.   Antoniani B.   Mottolese M.   Monteiro A. N.   Vici P.   Lara Rivera S.   Boulware D.   Cognetti F.   Bepler G.  

Cancer Investigation, Vol. 28, Iss. 2, 2009-09 ,pp. : 172-180

Informa Healthcare

Access to resources Recommend Favorite

CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab

By Petrioli Roberto   Licchetta Antonella   Roviello Giandomenico   Pascucci Alessandra   Francini Edoardo   Bargagli Gianluca   Conca Raffaele   Miano Salvatora Tindara   Marzocca Giuseppe   Francini Guido    

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite